cialis tadalafil 5 mg
1 INDICATIONS AND USAGE CIALIS ® is a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of: erectile dysfunction (ED) ( 1.1 ) the signs and symptoms of benign prostatic hyperplasia (BPH) ( 1.2 ) ED and the signs and symptoms of BPH (ED/BPH) ( 1.3 ) If CIALIS is used with finasteride to initiate BPH treatment, such use is recommended for up to 26 weeks ( 1.4 ). 1.1 erectile dysfunction CIALIS ® is indicated for the treatment of erectile dysfunction (ED). 1.2 benign prostatic hyperplasia CIALIS is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). 1.3 erectile dysfunction and benign prostatic hyperplasia CIALIS is indicated for the treatment of ED and the signs and symptoms of BPH (ED/BPH). 1.4 Limitation of Use If CIALIS is used with finasteride to initiate BPH treatment, such use is recommended for up to 26 weeks because the incremental benefit of CIALIS decreases from 4 weeks until 26 weeks, and the incremental benefit of CIALIS beyond 26 weeks is unknown [see Clinical Studies ( 14.3 )] .
eli lilly and company
TEAR YELLOW C5
C5 TEAR YELLOW
Related Pills
cialis tadalafil 5 mg
eli lilly and company
cialis tadalafil 5 mg
eli lilly and company
tadalafil 20 MG Oral Tablet Cialis
Eli Lilly and Company
tadalafil 20 MG Oral Tablet Cialis
Eli Lilly and Company
cialis tadalafil 10 mg
eli lilly and company
cialis tadalafil 5 mg
eli lilly and company
cialis tadalafil 10 mg
Eli Lilly and Company
Promethazine Hydrochloride Promethazine Hydrochloride 25 MG Oral Tablet
Global Pharmaceuticals, Division of Impax Lab
levofloxacin tablet film coated
zydus pharmaceuticals (usa) inc.
Levofloxacin 500 MG Oral Tablet
Zydus Pharmaceuticals (USA) Inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied CIALIS (
TADALAFIL) is supplied as follows: Four strengths of almond-shaped tablets are available in different sizes and different shades of yellow, and supplied in the following package sizes: 2.5 mg tablets debossed with “C 2 1/2” Blisters of 2 x 15 NDC 0002-4465-34 5 mg tablets debossed with “C 5” Bottles of 30 NDC 0002-4462-30 10 mg tablets debossed with “C 10” Bottles of 30 NDC 0002-4463-30 20 mg tablets debossed with “C 20” Bottles of 30 NDC 0002-4464-30 16.2 Storage Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature]. Keep out of reach of children.
More pills like TEAR C5